Card image cap

Type a Drug Name. Get the information you're looking for. It's that easy.


Psychopharmacology Database

Psychiatric Drug Reference

Psychopharmacopeia.com is a progressive web application aimed at providing clinicians with fast access to psychiatric drug information.

Quickly find indications (including off-label), dosing, side effects, clinically useful pharmacokinetic and pharmacodynamic information, drug-drug interactions, and prescribing pearls for special populations i.e. pregnant, lactating, patients with renal or hepatic impairment, elderly, etc. At last, a virtual Rolodex of psychopharm information, accessible anywhere and across devices.

105 Drugs So Far!

This site is being updated almost daily. Brexanolone is our most recent addition to the rapidly growing drug database.

Drug Tables

Search for Drugs by Mechanism of Action or Diagnosis

We now offer three separate tables in addition to the search bar, two sorted by mechanism of action (brand and generic), and a third new table organized by diagnoses (FDA-indicated and "off-label").

QT/QTc Quick Info

Concerned about QT prolongation when prescribing psychiatric medications?

Check out our new QT reference page with tables summarizing QT prolongation risk factors, including medication tables for both psych and non-psych meds (with comparison of high vs low risk of QT prolongation of various classes of psych meds).

Psychopharm Trivia

Fluoxetine (Prozac) was heralded as the prototype for the next generation of SSRI antidepressants, possessing fewer adverse effects and with a greater margin of safety when overdoses are consumed compared with the TCAs and also lacking the food-interaction toxicity of MAOIs. Fluoxetine was marketed in 1987, and within a few years, it boasted worldwide sales of nearly $ 1.2 billion a year.

From Foye's Principles of Medicinal Chemistry

Cytochrome P450 Table
CYP450

Preventing Drug-Drug Interactions

All drugs in the psychopharm database populate our CYP450 table, organized into substrates, inhibitors, and inducers of the major CYP pathways (1A2, 2D6, 2C9/C19, 3A4).

Dose Conversion Calculators
Card image cap

Side-by-side comparison of benzodiazepines

Converting a patient from one benzodiazepine to another? This benzodiazepine conversion tool shows the equipotent dose of the drug you're converting to, while comparing basic pharmacokinetic and prescribing information side-by-side.

Dose Conversion Calculators

Antipsychotic Conversion & Cross-Taper New

The antipsychotic conversion tool allows for quick calculation of equipotent antipsychotic doses for 20 different antipsychotic medications based on published chlorpromazine equivalents and provides suggested cross-taper schedule for making the switch!

Dose Conversion Calculators

Stimulant Conversion Calculator Beta

The stimulant dose conversion calculator is still in progress, and so far can convert doses to/from among Ritalin, Adderall, Vyvanse, Dexadrine, and Focalin. Look for updates to this conversion tool soon!


JAMA Psychiatry's Most Viewed
newspaper

Association Between High School Personality Phenotype and Dementia 54 Years Later in a US Sample
Posted on Tuesday October 15, 2019

This national US cohort study examines whether personality during adolescence—a time when preclinical dementia pathology is unlikely to be present—confers risk of dementia in later life and tests whether associations could be accounted for by health factors in adolescence or differed across socioeconomic status.

Shared Neural Phenotypes for Mood and Anxiety Disorders
Posted on Tuesday October 29, 2019

This meta-analysis evaluates the presence of transdiagnostic convergence in abnormalities in task-related brain activation in patients with mood disorders, anxiety disorders, and posttraumatic stress disorder.

Schizophrenia—An Overview
Posted on Tuesday October 29, 2019

This narrative review gives an overview of the causative mechanisms of schizophrenia from molecular, genetic, and psychosocial angles.

Ranking Antipsychotics for Efficacy and Safety in Schizophrenia
Posted on Tuesday November 05, 2019

This Viewpoint examines network meta-analyses that explore the efficacy of various antipsychotics in treating schizophrenia.

Cord Plasma Biomarkers of In Utero Acetaminophen Exposure and ADHD and ASD Risk
Posted on Tuesday October 29, 2019

This cohort study of mother-infant dyads examines the associations between cord plasma acetaminophen metabolites and physician-diagnosed attention-deficit/hyperactivity disorder, autism spectrum disorder, and other developmental disabilities.

logo

Developed & Designed by Kevin M. Nasky, D.O. • Built with Bootstrap, PHP & MySQL • Hosted by SiteGround
Last updated August 08 2019 14:18:39. Disclaimer: This website does not provide medical advice, nor is it a substitute for clinical judgment.